CVAC
CureVac NV
NASDAQ: CVAC · HEALTHCARE · BIOTECHNOLOGY
$4.66
+0.00% today
Updated 2026-04-30
Market cap
$1.05B
P/E ratio
6.96
P/S ratio
14.83x
EPS (TTM)
$0.67
Dividend yield
—
52W range
$3 – $6
Volume
1.1M
CureVac NV (CVAC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $125.66M | $130.62M | $1.51B | $1.16B | $860.47M | $788.25M | $802.83M |
| Cash & equivalents | $21.38M | $30.68M | $1.32B | $811.46M | $495.80M | $402.45M | $481.75M |
| Current assets | $73.07M | $57.17M | $1.39B | $940.02M | $584.03M | $478.38M | $526.41M |
| Total liabilities | $93.58M | $173.42M | $800.01M | $469.77M | $327.22M | $271.31M | $106.22M |
| Current liabilities | $28.13M | $28.09M | $247.62M | $357.73M | $156.22M | $186.39M | $72.35M |
| Long-term debt | — | $65.02M | — | — | — | — | — |
| Shareholder equity | $32.08M | $-42.80M | $711.35M | $688.48M | $533.25M | $516.94M | $696.61M |
| Retained earnings | $-416.07M | $-515.95M | $-645.07M | $-1.06B | $-1.31B | $-1.57B | $-1.40B |
| Accounts receivable | $6.86M | $17.15M | $1.82M | $53.74M | $9.00M | $39.51M | $32.90M |
| Inventory | $2.95M | $6.20M | $14.53M | $56.16M | $23.99M | $24.80M | $541000.00 |
| Goodwill | — | — | — | $0.00 | $12.46M | $12.46M | $12.46M |